SLGL
Sol-Gel Technologies Ltd.Healthcare · $219M market cap
Verdict
We can't put a fair value on SLGL right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow SLGL
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 1, 2026: 7 open-market purchases worth $804K. Why purchases matter
Purchases
Opaleye Management Inc.
Owns 10%+ · 2026-09-09
Bought
$213K
Opaleye Management Inc.
Owns 10%+ · 2026-09-08
Bought
$33K
Opaleye Management Inc.
Owns 10%+ · 2026-09-08
Bought
$233K
Opaleye Management Inc.
Owns 10%+ · 2026-09-04
Bought
$145K
Opaleye Management Inc.
Owns 10%+ · 2026-09-04
Bought
$64K
Opaleye Management Inc.
Owns 10%+ · 2026-09-02
Bought
$62K
Opaleye Management Inc.
Owns 10%+ · 2026-09-01
Bought
$54K
About Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates. Twyneo, an innovative…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works